Abstracts submission

• Information Regarding Abstracts
• The programme of the parallel sessions of the VI International Eastern Europe and Central Asia AIDS Conference (EECAAC 2018) will include presentations selected from submitted abstracts.
• Participants of the conference are invited to submit abstracts (concise descriptions) of their research or selected topic. If the participant wishes to present his abstract for an oral presentation, he should choose the option "oral presentation." Regardless of the inclusion of an oral report in the program, submitted abstracts will be included in the collection of abstracts of EECAAC 2018. If a participant chooses to not be considered for an oral presentation, the option "abstract for publication" should be chosen. It is also possible to apply for a poster presentation.
• Oral presentation, abstracts and poster presentations should focus on one of the predetermined topics outlined by the programme committees of the EECAAC 2018 within the tracks of "Science and Medicine," "Effective Prevention," "International Development Assistance," and "Civil Society."
• General information
• Abstracts are accepted in either Russian or English.
• The length of abstracts can range from 300 to 500 words.
• Abstracts should be structured as follows: title, introduction, purpose of the study, materials and methods, results, and conclusion.
• Each participant can submit no more than three (3) abstracts as the main author and an unlimited number as a co-author.
• Each author/co-author can present only one oral presentation.
• Only abstracts not previously published or submitted at other conferences can be submitted.
• All abbreviations, except for units of measure, can be used only after mentioning the full term.
• Text can not contain tables, graphics, or drawings.
• Procedure for submitting abstracts
• Abstracts can be submitted only through the official website of EECAAC 2018.
• Abstracts of participants of the Conference are reviewed by the members of the Thesis Commission, which includes representatives of the Programme Committees and recognized experts on HIV and related issues.
• All abstracts will be considered by the review commission. Each abstract will be evaluated by three independent experts. As a result of their evaluation, the commission will make one of four possible decisions: (1) recommend for oral presentation, (2) recommend as a poster presentation, (3) recommend for publication only or (4) reject. The authors will be notified of the commission's decision by e-mail. The abstract program is available on the official website of the Conference:
• en.eecaac2018.org/abstracts​
• Please note that abstracts for the inclusion of reports in the program of the parallel sessions of the EECAAC 2018 are accepted until October 1, 2017. Abstracts for inclusion in the printed collection materials of the EECAAC 2018 are accepted until March 1, 2018. The organizers of EECAAC 2018 undertake to ensure the participation of speakers (travel and accommodation).
• Procedures for reviewing and accepting abstracts:
• Abstracts can be submitted only through the official website of EECAAC 2018.
• Abstracts of participants of the Conference are reviewed by the members of the Thesis Commission, which includes representatives of the Program Committees and recognized experts on HIV and related issues.
• All abstracts will be considered by the review commission. Each abstract will be evaluated by three independent experts. As a result of their evaluation, the commission will make one of four possible decisions: (1) recommend for oral presentation, (2) recommend as a poster presentation, (3) recommend for publication only or (4) reject. The authors will be notified of the commission's decision by e-mail.
• General information:
• Abstracts are accepted in either Russian and English.
• The length of abstracts can range from 300 to 500 words.
• Abstracts should be structured as follows: title, introduction, purpose of the study, materials and methods, results, and conclusion.
• Each participant can submit no more than three (3) abstracts as the main author and an unlimited number as a co-author.
• Each author/co-author can present only one oral presentation.
• Only abstracts not previously published or submitted at other conferences can be submitted.
• All abbreviations, except for units of measure, can be used only after mentioning the full term.
• Text can not contain tables, graphics, or drawings.
• Below please find the topic areas of EECAAC2018. Submitted abstracts should fall under one of the following themes:
• 
  
• "Science and Medicine" track:
• Basic and biomedical research in the field of HIV infection
• HIV surveillance in Eastern Europe and Central Asia
• Diversity of the HIV virus and the human body
• New approaches in monitoring the spread of HIV infection
• Aspects of gender and age in HIV infection
• Vulnerable populations
• Social, economic and biobehavioral research in HIV infection and drug addiction
• The context of HIV infection
• The concept of "Treatment for all" in Eastern Europe and Central Asia - opportunities and obstacles
• Antiretroviral therapy: present and future, new WHO recommendations on HIV treatment, adherence to antiretroviral therapy
• Cascade of medical care for people living with HIV
• New strategies for HIV/AIDS diagnostics and HIV treatment monitoring
• Pharmacoeconomic research
• HIV coinfections (tuberculosis, viral hepatitis, etc.)
• Adherence to HIV treatment
• Palliative care for people with HIV/AIDS
• Reproductive health of people living with HIV
• Further ways to reduce the transmission of HIV from mother to child
• HIV infection in children and adolescents
• Specific prevention of HIV infection
• Miscellaneous topics within the "Science and Medicine" track
• 
  
• "Effective Prevention" track:
• Prevention of HIV infection among different population groups (general population, vulnerable groups, migrants, youth, working population, prisoners, servicemen, etc.), effective mechanisms and approaches, including new and electronic technologies
• Prevention of HIV infection in medical settings and during invasive non-medical procedures
• Development of new technologies for the prevention of HIV infection, such as: vaccines, microbicides, pre-exposure prophylaxis, circumcision, and combined methods
• The role of information and training programs in the prevention and treatment of HIV infection
• Cultural, age and gender aspects to consider when designing and implementing of prevention programs;
• Evidence-based research on the effectiveness of preventive measures
• Medical prophylaxis of HIV infection
• Prevention of HIV infection among drug users
• Miscellaneous topics within the "Effective Prevention" track
• 
  
• "International Development Assistance" track:
• Development of regional health systems
• Development and effective strategies of bilateral and multilateral cooperation
• Socioeconomic aspects of the international development programs
• Miscellaneous topics within the "Effective Prevention" track
• 
  
• "Civil Society" track:
• Retention of patients and improvement of adherence
• Effective strategies for preventing and combating HIV among people who use drugs
• Effective strategies for preventing and combating HIV among sex workers
• Effective strategies for preventing and combating HIV among LGBT communities
• Effective strategies for preventing and combating HIV among adolescents and youth
• Effective strategies for preventing and combating HIV among the general population
• Gender considerations in the organization and implementation of projects
• Community-driven projects
• Improving access to treatment and monitoring treatment of HIV infection and concomitant diseases
• Patient rights, stigma and discrimination
• Sustainable project financing